Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?

Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?: A Randomized Clinical Trial

Aim of the study: In this study, the change in emotional intelligence will be assessed before and after group CBT sessions in male patients with substance use disorder in the inpatient department of the addiction unit at Mansoura University Hospital.

Study Overview

• Status: Not yet recruiting
• Conditions: Substance Use Disorders
• Intervention / Treatment: Behavioral: group cognitive behavioral therapy sessions

Detailed Description

Between the ages of fifteen and sixty-four, 5% of the global population, or nearly 200 million people, reported consuming at least one illegal substance per year. According to the 2008 World Drug Report, cannabis has a prevalence of 3.8%, compared to 0.6% for amphetamines and opiates, 0.3% for cocaine and heroin, and 0.2% for ecstasy. A cross-sectional study by [1] in Egypt with 2552 participants found that sedatives (8.7%) were the most commonly abused drugs, followed by alcohol (6.7%), cannabinoids (6.6%), and tramadol (2.4%). The prevalence of drug use was 8.9% for cigarette smoking followed by sedatives (4.3%), hashish (3.6%), alcohol (2.7%), cannabinoids (1.4%,) and tramadol (1.0%).

Lander et al. [2] believed that substance use disorder (SUD) is one of the most severe psychosocial traumas posing environmental, psychological, behavioral, and emotional challenges to individuals. It can cause obstacles for persons, families, and cultural foundations, endangering countries' dynamics. SUD is a brain disorder that impacts the person's behavior, manifests as psychological and physiological symptoms; and persists for a long duration despite its harmful and detrimental consequences.

Previous research has shown that different factors impact starting and following addiction. These factors are; 1) Individuals, such as the presence or lack of personality traits that make an individual vulnerable to addiction, for example, non-assertiveness as an individual factor. 2) Social factors, such as parental addiction, lack of parental control, availability of substances, presence of addicted peers, and so on [3].

Emotional intelligence (EQ) is a relatively recent behavioral model rising to prominence with Daniel Goleman's 1995 Book called 'Emotional Intelligence'. The early emotional intelligence theory was originally developed during the 1970s and 80s by the work and writings of psychologists Howard Gardner (Harvard), Peter Salovey (Yale), and John 'Jack' Mayer (New Hampshire) [4]. Emotional intelligence consists of the ability to motivate individuals such as endurance against frustration, impulse control, mood modification, and avoiding destructive stress to prevent mental disorders [5].

Emotional intelligence is a set of non-cognitive skills and abilities that can help a person deal with environmental stressors, according to [6]. Azzam and Elghonemy's [7] research demonstrated that emotional regulation was associated with mood improvement and a higher likelihood of SUD recovery. They found emotional intelligence to be an important factor in the treatment of substance use. [8] suggested that improvements in EI through treatment interventions can be an effective way to improve not only EI but also psychiatric symptoms both for the short term and the long term after rehabilitation.

• Study Type: Interventional
• Enrollment (Estimated): 84
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: hassan M sonbol; Phone Number: +201003903567; Email: hassansonbol@mans.edu.eg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Male patients with DSM5 diagnosis of substance use disorder
2. Age range 18 to 55 years
3. Agreeing to participate in the research and giving written informed consent
4. Average IQ as evidenced by the Wechsler Adult Intelligence scale

Exclusion Criteria:

1. Psychiatric comorbidities
2. Any neurological or medical conditions interfering with the cognitive abilities

4-Illiterate patients

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: CBT intervention arm; patients with substance use disorder in the inpatient department of the addiction unit in Mansoura University Hospital who will receive group CBT sessions	Behavioral: group cognitive behavioral therapy sessions; 12 group CBT sessions based on catching and challenging cognitive errors and behavioral techniques to deal with substance use problems
No Intervention: NON-CBT control arm; age and gender-matched patients with substance use disorder in the outpatient clinics of the addiction unit in Mansoura University Hospital who will not receive group CBT sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
emotional intelligence	Trait Emotional Intelligence Questionnaire (TEIQue-SF): The Trait Emotional Intelligence Scale (Petrides, 2009b) includes 30 items that assess the following four factors: well-being, self-control, sociability (each with six items), and emotionality (eight items), as well as four additional items 3, 14, 18, and 29, which do not belong to any factor and directly contribute to the evaluation of the overall degree of the trait emotional intelligence, as indicated by the scoring key. The questionnaire is graded on a seven-point Likert scale, with responses ranging from 1 (strongly disagree) to 7 (strongly agree), with higher scores indicating higher emotional intelligence. This TEIQue-SF scale has been used in numerous studies (Cooper & Petrides, 2010; Perera, 2015) owing to its good psychometric properties. The Arabic version was validated by Al-Dassean, (2023).	6 months

Collaborators and Investigators

• Sponsor: Egyptian Medical Syndicate

Publications and helpful links

General Publications

• Kabbash I, Zidan O, Saied S. Substance abuse among university students in Egypt: prevalence and correlates. East Mediterr Health J. 2022 Jan 31;28(1):31-40. doi: 10.26719/emhj.22.001.
• Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health. 2013;28(3-4):194-205. doi: 10.1080/19371918.2013.759005.
• 3-Sho'aKazemi M. The comparative analysis of the relationship between coping strategies and attitude toward drug addicts (Persian). Addiction Studies; 2008.
• 4-Nazari K, Emami M. Emotional Intelligence: Understanding, applying, and measuring. Journal of Applied Sciences Research. 2012;8(3):1594-1607.
• 5-Bar-on R. The Emotional Quotient Inventory (EQ-i). A Test of Emotional Intelligence. Jossey. Bass; 2006.
• 6-Shareh, H., & Foshtanqi, K. (2019). The role of emotional intelligence and marital satisfaction in women's quality of life: Structural equation modeling. Journal of Fundamentals of Mental Health, 21(2), 109-120.
• 7-Azzam H, Elghonemy S. Emotional intelligence and substance abuse: A possible relation. Current Psychiatry. 2008; 15:113.25.
• 8-Henning, C., Crane, A. G., Taylor, R. N., & Parker, J. D. (2021). Emotional intelligence: relevance and implications for addiction. Current Addiction Reports, 8, 28-34.

Study record dates

Study Major Dates

• Study Start (Estimated): April 1, 2024
• Primary Completion (Estimated): September 1, 2024
• Study Completion (Estimated): October 1, 2024

Study Registration Dates

• First Submitted: March 5, 2024
• First Submitted That Met QC Criteria: March 12, 2024
• First Posted (Actual): March 15, 2024

Study Record Updates

• Last Update Posted (Actual): March 15, 2024
• Last Update Submitted That Met QC Criteria: March 12, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Chemically-Induced Disorders; Substance-Related Disorders
• Other Study ID Numbers: CBT IN substance use disorder

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No